Ghiath M. Sukhtian

Director, Outlook Therapeutics, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Aug 12, 2026Bought 2,525,252 shares at $0.99 of Outlook Therapeutics, Inc.²
May 27, 2025Granted 4,285,714 shares at $1.40 of Outlook Therapeutics, Inc.³
Jan 17, 2025Exercised options 3,458,571 shares at $2.51 of Outlook Therapeutics, Inc.⁴
Mar 18, 2024Granted 2,305,714 shares of Outlook Therapeutics, Inc.⁵
Dec 28, 2022Granted 14,230,418 shares at $0.88 of Outlook Therapeutics, Inc.⁶
Apr 21, 2022Other 27,982,529 shares of Outlook Therapeutics, Inc.⁷
Nov 29, 2021Bought 16,000,000 shares at $1.25 of Outlook Therapeutics, Inc.⁸

The numbers on this page point here. Each one links to the record it came from.